Loading clinical trials...
Loading clinical trials...
This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing anatomical-to-metabolic mapping based o...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
NCT05671510 · Non Small Cell Lung Cancer
NCT06043817 · Non-Small Cell Lung Cancer, NSCLC, and more
NCT07177937 · Small Cell Lung Cancer, Melanoma, and more
NCT06426511 · Lung Cancer, Nonsmall Cell
NCT06498635 · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, and more
Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou
The First Affiliated Hospital of Nanchang University
Jiangxi, Nanchang
Shanghai East Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions